Enhanced response to basiliximab in a patient with aplastic anemia after treatment with standard immunosuppression

被引：1

作者：

Berman, JA ^{[1
]}

Patel, K ^{[1
]}

Caro, J ^{[1
]}

机构：

[1] Thomas Jefferson Univ Hosp, Dept Med Hematol Oncol, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2002年 / 71卷 / 01期

关键词：

D O I：

10.1002/ajh.10177

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：64 / 64

页数：1

共 8 条

[1] Hepatitis-associated aplastic anemia [J].

Brown, KE ;

Tisdale, J ;

Barrett, AJ ;

Dunbar, CE ;

Young, NS .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1059-1064

[2]

Cronin D C 2nd, 2000, Clin Liver Dis, V4, P619, DOI 10.1016/S1089-3261(05)70130-6

[3] Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine [J].

Frickhofen, N ;

Rosenfeld, SJ .

SEMINARS IN HEMATOLOGY, 2000, 37 (01) :56-68

[4] Immunosuppressive therapy - New concepts [J].

Jain, A ;

Khanna, A ;

Molmenti, EP ;

Rishi, N ;

Fung, JJ .

SURGICAL CLINICS OF NORTH AMERICA, 1999, 79 (01) :59-+

[5] Cyclophosphamide and other new agents for the treatment of severe aplastic anemia [J].

Tisdale, JF ;

Dunn, DE ;

Maciejewski, J .

SEMINARS IN HEMATOLOGY, 2000, 37 (01) :102-109

[6] Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia [J].

Young, NS .

SEMINARS IN HEMATOLOGY, 2000, 37 (01) :3-14

[7] Mechanisms of disease - The pathophysiology of acquired aplastic anemia [J].

Young, NS ;

Maciejewski, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (19) :1365-1372

[8]

Zeng WH, 1999, BLOOD, V93, P3008

← 1 →